Recalls & Warnings April 09, 2014 Maker of Relaxation Drink Warned For Melatonin Ingredient On March 27, 2014, the FDA issued a warning letter to Dewmar International BMC, Inc
Peptide therapy is not a one-size-fits-all treatment
Early data and anecdotal reports indicate the half-life of BPC-157 might range anywhere from a few hours up to 24 hours, though precise data is limited
BPC-157 supplied by NewBioRx is intended strictly for laboratory research use and is not approved for human or veterinary applications
Research facilities must implement specific storage requirements to maintain peptide integrity and get reliable experimental results
They might work with doctors back home, offer telemedicine, or give advice on managing nutrients long-term